The US Bankruptcy Court granted an order for the joint administration of the Chapter 11 bankruptcy cases of Clarus Therapeutics Holdings, Inc. and its affiliates on September 7, 2022. The affiliates include Clarus Therapeutics, Inc. The cases would be jointly administered for administrative and procedural purposes. Clarus Therapeutics Holdings, Inc. has been designated as the lead debtor.